Martina Klein

Person

Heiligenhaus, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use
- Patent number 9,051,316
- Issue date Jun 9, 2015
- Bayer Intellectual Property GmbH
- Lars Bärfacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
- Patent number 8,436,180
- Issue date May 7, 2013
- Bayer Intellectual Property GmbH
- Lars Bärfacker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclically substituted furopyrimidine derivatives and use thereof
- Patent number 8,324,222
- Issue date Dec 4, 2012
- Bayer Intellectual Property GmbH
- Thomas Lampe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treating pulmonary hypertension
- Patent number 8,304,406
- Issue date Nov 6, 2012
- Bayer Intellectual Property GmbH
- Martina Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acyclically substituted furopyrimidine derivatives and use thereof
- Patent number 8,183,246
- Issue date May 22, 2012
- Bayer Intellectual Property GmbH
- Thomas Lampe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
LTBP2 as a biomarker and diagnostic target
- Patent number 8,088,584
- Issue date Jan 3, 2012
- Bayer Schering Pharma Aktiengesellschaft
- Stefan Golz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDES AND THEIR USE
- Publication number 20140100243
- Publication date Apr 10, 2014
- Bayer Intellectual Property GmbH
- Lars BÄRFACKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Th...
- Publication number 20110124665
- Publication date May 26, 2011
- Bayer Schering Pharma Aktiengesellschaft
- Thomas Lampe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20110111394
- Publication date May 12, 2011
- Bayer Schering Pharma Aktiengesellschaft
- Stefan Golz
- G01 - MEASURING TESTING
Information Patent Application
Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypert...
- Publication number 20100144728
- Publication date Jun 10, 2010
- BAYER SCHERING PHARMA AG
- Georges Von Degenfeld
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED-4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINAMIDES AND USE THEREOF
- Publication number 20100136142
- Publication date Jun 3, 2010
- BAYER SCHERING PAHARMA AKTIENGESELLSCHAFT
- Lars Bärfacker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATING PULMONARY HYPERTENSION
- Publication number 20100113452
- Publication date May 6, 2010
- Bayer Healthcare AG
- Martina Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRSS23 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20100104501
- Publication date Apr 29, 2010
- Stefan Golz
- G01 - MEASURING TESTING
Information Patent Application
CRTAC AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20100081136
- Publication date Apr 1, 2010
- Stefan Golz
- G01 - MEASURING TESTING
Information Patent Application
Diaryl Urea for Treating Pulmonary Hypertension
- Publication number 20100035888
- Publication date Feb 11, 2010
- Bater Healthcare AG
- Peter Sandner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LTBP2 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20100028264
- Publication date Feb 4, 2010
- Stefan Golz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Novel, Acyclically Substituted Furopyrimidine Derivatives and Use T...
- Publication number 20090318475
- Publication date Dec 24, 2009
- Bayer Healthcare AG
- Thomas Lampe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diaryl Ureas for Treating Pulmonary Hypertension
- Publication number 20090176791
- Publication date Jul 9, 2009
- Bayer Healthcare AG
- Peter Sandner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Martina Klein

Person

Patents Grantslast 30 patents

Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use

Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof

Cyclically substituted furopyrimidine derivatives and use thereof

Compounds for treating pulmonary hypertension

Acyclically substituted furopyrimidine derivatives and use thereof

LTBP2 as a biomarker and diagnostic target

Patents Applicationslast 30 patents

SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDES AND THEIR USE

Novel, Cyclically Substituted Furopyrimidine Derivatives and Use Th...

CTGF AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET

Oxazolidinone For The Treatment And Prophylaxis Of Pulmonary Hypert...

SUBSTITUTED-4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINAMIDES AND USE THEREOF

COMPOUNDS FOR TREATING PULMONARY HYPERTENSION

PRSS23 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET

CRTAC AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET

Diaryl Urea for Treating Pulmonary Hypertension

LTBP2 AS A BIOMARKER, THERAPEUTIC AND DIAGNOSTIC TARGET

Novel, Acyclically Substituted Furopyrimidine Derivatives and Use T...

Diaryl Ureas for Treating Pulmonary Hypertension